LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Travel Businesses for Sale
Banquet Halls & Catering Businesses for Sale
Home Based Business Opportunities
Automotive Businesses for Sale
Transport & Shipping Businesses for Sale
Startup Investment Opportunities
Smoke & Vape Shops for Sale
Technology Businesses for Sale
Post Office Businesses for Sale
Healthcare & Medical Businesses for Sale
Child Care & Education Franchise Opportunities
Convenience Store & Lotto Franchises for Sale
Gas Station & Car Wash Franchises for Sale
Pet Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Bars & Pubs Franchises for Sale
Wholesale & Distribution Franchise Opportunities
Fitness & Wellness Franchises for Sale
Healthcare & Medical Franchise Opportunities
Real Estate & Property Management Franchise for Sale
Industrial Units for Sale or Rent
Retail Spaces for Lease or Sale
Houses & Condos for Sale or Lease
Retail Buildings for Sale or Lease
Land & Developments for Sale
Mixed Use Buildings for Sale or Rent
Miscellaneous Properties for Sale or Lease
Office Buildings for Sale or Rent
Medical Office Spaces for Sale or Rent
Commercial Spaces for Sale or Lease
An email will be sent to registered email address.
Please select if you are: